on April 2, 2007
Published online before print April 2, 2007, doi: 10.1161/CIRCULATIONAHA.106.668665
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 5, 2006
From the Program in Integrative Cardiac Metabolism (N.S., J.M.O., K.M.P., E.D.L.) and Center for Cardiovascular Research (N.S., J.M.O., R.D.M., K.M.P., P.M.B., E.D.L.), University of Illinois at Chicago, College of Medicine, Chicago; Department of Environmental and Biomolecular Systems (G.W.), Oregon Health and Science University, Beaverton; Department of Molecular and Cellular Physiology (K.F.L.), Pennsylvania State University Medical School, Hershey; and Department of Internal Medicine (K.B., H.T.), Division of Cardiology, University of Texas Houston Medical School, Houston. * To whom correspondence should be addressed. E-mail: dougl{at}uic.edu.
Background--Transport rates of long-chain free fatty acids into mitochondria via carnitine palmitoyltransferase I relative to overall oxidative rates in hypertrophied hearts remain poorly understood. Furthermore, the extent of glucose oxidation, despite increased glycolysis in hypertrophy, remains controversial. The present study explores potential compensatory mechanisms to sustain tricarboxylic acid cycle flux that resolve the apparent discrepancy of reduced fatty acid oxidation without increased glucose oxidation through pyruvate dehydrogenase complex in the energy-poor, hypertrophied heart. Methods and Results--We studied flux through the oxidative metabolism of intact adult rat hearts subjected to 10 weeks of pressure overload (hypertrophied; n=9) or sham operation (sham; n=8) using dynamic 13C-nuclear magnetic resonance. Isolated hearts were perfused with [2,4,6,8,10,12,14,16-13C8] palmitate (0.4 mmol/L) plus glucose (5 mmol/L) in a 14.1-T nuclear magnetic resonance magnet. At similar tricarboxylic acid cycle rates, flux through carnitine palmitoyltransferase I was 23% lower in hypertrophied (P<0.04) compared with sham hearts and corresponded to a shift toward increased expression of the L-carnitine palmitoyltransferase I isoform. Glucose oxidation via pyruvate dehydrogenase complex did not compensate for reduced palmitate oxidation rates. However, hypertrophied rats displayed an 83% increase in anaplerotic flux into the tricarboxylic acid cycle (P<0.03) that was supported by glycolytic pyruvate, coincident with increased mRNA transcript levels for malic enzyme. Conclusions--In cardiac hypertrophy, fatty acid oxidation rates are reduced, whereas compensatory increases in anaplerosis maintain tricarboxylic acid cycle flux and account for a greater portion of glucose oxidation than previously recognized. The shift away from acetyl coenzyme A production toward carbon influx via anaplerosis bypasses energy, yielding reactions contributing to a less energy-efficient heart.
Accepted on February 20, 2007
Recruitment of Compensatory Pathways to Sustain Oxidative Flux With Reduced Carnitine Palmitoyltransferase I Activity Characterizes Inefficiency in Energy Metabolism in Hypertrophied Hearts
Natalia Sorokina PhD,
Key words: fatty acids • glucose • hypertrophy • isotopes • metabolism
This article has been cited by other articles:
 |
|
 |
|
  H. Bugger, M. Schwarzer, D. Chen, A. Schrepper, P. A. Amorim, M. Schoepe, T. D. Nguyen, F. W. Mohr, O. Khalimonchuk, B. C. Weimer, et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure Cardiovasc Res, November 11, 2009; (2009) cvp344v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Schroeder, H. J. Atherton, D. R. Ball, M. A. Cole, L. C. Heather, J. L. Griffin, K. Clarke, G. K. Radda, and D. J. Tyler Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy FASEB J, August 1, 2009; 23(8): 2529 - 2538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Sack Innate Short-Circuiting of Mitochondrial Metabolism in Cardiac Hypertrophy: Identification of Novel Consequences of Enhanced Anaplerosis Circ. Res., March 27, 2009; 104(6): 717 - 719. [Full Text] [PDF]
|
|
|
|
|
|
K. M. Pound, N. Sorokina, K. Ballal, D. A. Berkich, M. Fasano, K. F. LaNoue, H. Taegtmeyer, J. M. O'Donnell, and E. D. Lewandowski Substrate-Enzyme Competition Attenuates Upregulated Anaplerotic Flux Through Malic Enzyme in Hypertrophied Rat Heart and Restores Triacylglyceride Content: Attenuating Upregulated Anaplerosis in Hypertrophy Circ. Res., March 27, 2009; 104(6): 805 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sacca Heart Failure as a Multiple Hormonal Deficiency Syndrome Circ Heart Fail, March 1, 2009; 2(2): 151 - 156. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Ingwall Energy metabolism in heart failure and remodelling Cardiovasc Res, February 15, 2009; 81(3): 412 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Qanud, M. Mamdani, M. Pepe, R. J. Khairallah, J. Gravel, B. Lei, S. A. Gupte, V. G. Sharov, H. N. Sabbah, W. C. Stanley, et al. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2098 - H2105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tuunanen, E. Engblom, A. Naum, K. Nagren, M. Scheinin, B. Hesse, K.E. Juhani Airaksinen, P. Nuutila, P. Iozzo, H. Ukkonen, et al. Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy Circulation, September 16, 2008; 118(12): 1250 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Lehman, S. Boudina, N. H. Banke, N. Sambandam, X. Han, D. M. Young, T. C. Leone, R. W. Gross, E. D. Lewandowski, E. D. Abel, et al. The transcriptional coactivator PGC-1{alpha} is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H185 - H196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ashrafian, M. P. Frenneaux, and L. H. Opie Metabolic Mechanisms in Heart Failure Circulation, July 24, 2007; 116(4): 434 - 448. [Abstract] [Full Text] [PDF]
|
|